Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01704196 · ClinicalTrials.gov registry record · Phase 2
A Multi-Center Trial of Nepicastat for Cocaine Dependence
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 179
- Enrollment target
NCT01704196 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 179 participants.
The verdict
NCT01704196, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 179 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of Nepicastat in improving the number of subjects that achieve abstinence from cocaine and reducing cocaine use in subjects with cocaine dependence.
Interventions
- DRUG Placebo
- DRUG Nepicastat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01704196
The ClinicalTrials.gov registry entry for NCT01704196 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01704196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01704196 about?
NCT01704196 is a clinical study titled "A Multi-Center Trial of Nepicastat for Cocaine Dependence". The objective of this study is to evaluate the safety and efficacy of Nepicastat in improving the number of subjects that achieve abstinence from cocaine and reducing cocaine use in subjects with cocaine dependence.
What is the current status of trial NCT01704196?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 179 participants. The study started on 2013-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01704196?
The interventions under investigation include: Placebo (DRUG), Nepicastat (DRUG).
Who is sponsoring clinical trial NCT01704196?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.